"Company","Parent Company","Penalty Amount","Subtraction From Penalty","Penalty Amount Adjusted For Eliminating Multiple Counting","Penalty Year","Penalty Date","Offense Group","Primary Offense","Secondary Offense","Description","Level of Government","Action Type","Agency","Civil/Criminal","Prosecution Agreement","Court","Case ID","Private Litigation Case Title","Lawsuit Resolution","Facility State","City","Address","Zip","NAICS Code","NAICS Translation","HQ Country of Parent","HQ State of Parent","Ownership Structure","Parent Company Stock Ticker","Major Industry of Parent","Specific Industry of Parent","Info Source","Notes"
"United Therapeutics Corporation","United Therapeutics","$210,000,000","$0","$210,000,000","2017","20171220","government-contracting-related offenses","False Claims Act and related","","Pharmaceutical company United Therapeutics Corporation agreed to pay $210 million to resolve claims that it used a foundation as a conduit to pay the copays of Medicare patients taking its pulmonary arterial hypertension drugs, in violation of the False Claims Act.","federal","agency action","Justice Department Civil Division","civil","","","","","","","","","","","","USA","Maryland","publicly traded","UTHR","pharmaceuticals","pharmaceuticals","https://www.justice.gov/opa/pr/drug-maker-united-therapeutics-agrees-pay-210-million-resolve-false-claims-act-liability",""
